Psychiatry Research: Neuroimaging
Volume 146, Issue 2 , Pages 127-135 , 31 March 2006

Grey and white matter differences in brain energy metabolism in first episode schizophrenia: 31P-MRS chemical shift imaging at 4 Tesla

  • J. Eric Jensen

      Affiliations

    • Brain Imaging Center, McLean Hospital, Belmont, MA, USA
    • Department of Psychiatry, Harvard Medical School, Boston, MA, USA
    • Corresponding Author InformationCorresponding author. Room 208, Brain Imaging Center, McLean Hospital, 115 Mill Street, Belmont, MA 02478-9106, USA. Tel.: +1 617 855 3366; fax: +1 617 855 2770.
    • ,
  • Jodi Miller

      Affiliations

    • Department of Medical Biophysics, University of Western Ontario, Canada
    • Diagnostic Radiology and Nuclear Medicine, St. Joseph's Health Care, London, Ontario, Canada
    • ,
  • Peter C. Williamson

      Affiliations

    • Department of Medical Biophysics, University of Western Ontario, Canada
    • Department of Psychiatry, University of Western Ontario, Canada
    • ,
  • Richard W.J. Neufeld

      Affiliations

    • Department of Psychology, University of Western Ontario, Canada
    • ,
  • Ravi S. Menon

      Affiliations

    • Department of Medical Biophysics, University of Western Ontario, Canada
    • Laboratory for Magnetic Resonance Imaging Research, Robarts Research Institute, London, Ontario, Canada
    • ,
  • Ashok Malla

      Affiliations

    • Douglas Hospital, McGill University, Montreal, Quebec, Canada
    • ,
  • Rahul Manchanda

      Affiliations

    • Department of Psychiatry, University of Western Ontario, Canada
    • ,
  • Betsy Schaefer

      Affiliations

    • Department of Psychiatry, University of Western Ontario, Canada
    • ,
  • Maria Densmore

      Affiliations

    • Diagnostic Radiology and Nuclear Medicine, St. Joseph's Health Care, London, Ontario, Canada
    • ,
  • Dick J. Drost

      Affiliations

    • Department of Medical Biophysics, University of Western Ontario, Canada
    • Department of Psychiatry, University of Western Ontario, Canada
    • Diagnostic Radiology and Nuclear Medicine, St. Joseph's Health Care, London, Ontario, Canada

Received 6 July 2005 ,Revised 20 October 2005 ,Accepted 28 November 2005.

References 

  1. Andreasen NC. Scale for the Assessment of Negative Symptoms. Iowa City, IA: University of Iowa; 1984;
  2. Andreasen NC. Scale for the Assessment of Positive Symptoms. Iowa City, IA: University of Iowa; 1984;
  3. Benes MF. Model generation and testing to probe neural circuitry in the cingulate cortex of post-mortem schizophrenic brain. Schizophrenia Bulletin. 1998;24:219–230
  4. Brown TR, Kincaid BM, Ugurbil K. NMR chemical shift imaging in three dimensions. Proceedings of the National Academy of Sciences of the United States of America. 1982;79:3523–3526
  5. Buchsbaum MS, Tang CY, Peled S, Gudbjartsson H, Lu D, Hazlett EA, et al. MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia. Neuroreport. 1998;9:425–430
  6. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll A, Lyoo IK, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Archives of General Psychiatry. 2004;61(5):450–458
  7. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview (SCID) for DSM-IV Axis 1 Disorders. Washington, DC: American Psychiatric Press Inc.; 1997;
  8. Gangadhar BN, Jayakumar PN, Subbakrishna DK, Janakiramaiah N, Keshavan MS. Basal ganglia high-energy phosphate metabolism in neuroleptic-naïve patients with schizophrenia: a 31-phosphorus magnetic resonance spectroscopic study. American Journal of Psychiatry. 2004;161:1304–1306
  9. Hetherington HP, Spencer DD, Vaughan JT, Pan JW. Quantitative 31P spectroscopic imaging of human brain at 4 Tesla: assessment of gray and white matter differences of phosphocreatine and ATP. Magnetic Resonance in Medicine. 2001;45:46–52
  10. Hinsberger AD, Williamson PC, Carr TJ, Stanley JA, Drost DJ, Densmore M, et al. Magnetic resonance imaging volumetric and phosphorus-31 magnetic resonance spectroscopy measurements in schizophrenia. Journal of Psychiatry and Neuroscience. 1997;22(2):111–117
  11. Jensen JE, Al-Semaan YM, Williamson PC, Neufeld WJ, Menon RS, Schaefer B, et al. Region-specific changes in phospholipid metabolism in chronic, medicated schizophrenia: 31P chemical-shift imaging study at 4.0 Tesla. British Journal of Psychiatry. 2002;180:39–44
  12. Jensen JE, Drost DJ, Menon RS, Williamson PC. In vivo brain 31P-MRS: measuring the phospholipid resonances at 4 Tesla from small voxels. NMR in Biomedicine. 2002;15:338–347
  13. Jensen JE, Miller J, Williamson PC, Neufeld WJ, Menon RS, Malla A, et al. Focal changes in brain energy phospholipid metabolism in first-episode schizophrenia. British Journal of Psychiatry. 2004;184:409–415
  14. Jones EG. Cortical development and thalamic pathology in schizophrenia. Schizophrenia Bulletin. 1997;23:483–501
  15. Keshavan MS, Stanley JA, Pettegrew JW. Magnetic resonance spectroscopy in schizophrenia: methodological issues and findings: Part II. Biological Psychiatry. 2000;48:369–380
  16. Kong J, Shepel PN, Holden CP, Mackiewicz M, Pack AI, Geiger JD. Brain glycogen decreases with increased periods of wakefulness: implications for homeostatic drive to sleep. Journal of Neuroscience. 2002;22(13):5581–5587
  17. Lipska BK, Weinberger DR. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced sterotypic behaviors in the rat. Developmental Brain Research. 1993;75:213–222
  18. Lim KO, Adalsteinsson E, Spielmen D, Sullivan EV, Rosenbloom MJ, Pfefferbaum A. Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia. Archives if General Psychiatry. 1998;55:346–352
  19. Mason GF, Chu WJ, Vaughan JT, Ponder SL, Twieg DB, Adams D, et al. Evaluation of 31P metabolite differences in human cerebral gray and white matter. Magnetic Resonance in Medicine. 1998;39(3):346–353
  20. Paradiso S, Andreasen NC, Crespo-Facorro B, O'Leary DS, Watkins GL, Ponto-Boles LL, et al. Emotions in unmedicated patients with schizophrenia during evaluation with positron emission tomography. American Journal of Psychiatry. 2003;160:1775–1783
  21. Potwarka J, Drost DJ, Williamson PC, Carr T, Canaran G, Rylett WJ, et al. A 1H decoupled 31P chemical shift imaging study of medicated schizophrenic patients and healthy controls. Biological Psychiatry. 1999;45:687–693
  22. Shirayama Y, Yano T, Takahashi K, Takahashi S, Ogino T. In vivo 31P NMR spectroscopy shows an increase in glycerophosphorylcholine concentration without alterations in mitochondrial function in the prefrontal cortex of medicated schizophrenic patients at rest. European Journal of Neuroscience. 2004;20:749–756
  23. Soyka M, Koch W, Möller HJ, Ruther T, Tatsch K. Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET study. European Archives of Psychiatry and Clinical Neuroscience. 2005;255(5):308–312
  24. Swanson RA, Sagar SM, Sharp FR. Regional brain glygogen stores and metabolism during complete global ischaemia. Neurological Research. 1989;11:24–28
  25. Théberge J, Bartha R, Drost DJ, Menon RS, Malla A, Takhar J, et al. Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. American Journal of Psychiatry. 2002;159(11):1944–1946
  26. Volz H-P, Rzanny R, RoBger G, Hubner G, Kreitschmann-Andermahr I, Alois-Kaiser W, et al. Decreased energy demanding processes in the frontal lobes of schizophrenics due to neuroleptics? A 31P-magneto-resonance spectroscopic study. Psychiatry Research: Neuroimaging. 1997;76:123–129
  27. Williamson PC, Drost DJ. Brain phospholipid metabolism in schizophrenia with 31P magnetic resonance spectroscopy. In: Phospholipid Spectrum Disorder in Psychiatry and Neurology. 2nd edition. Carnforth, Lancashire, UK: Marius Press; 2003;p. 221–238
  28. Yacubian J, de Castro CC, Ometto M, Barbosa E, Pires de Camargo C, Tavares H, et al. 31P-spectroscopy of frontal lobe in schizophrenia: alterations in phospholipid and high-energy phosphate metabolism. Schizophrenia Research. 2002;58(2–3):117–122

PII: S0925-4927(05)00205-2

doi: 10.1016/j.pscychresns.2005.11.004

Psychiatry Research: Neuroimaging
Volume 146, Issue 2 , Pages 127-135 , 31 March 2006

Article Tools

* Image Usage & Resolution